• Startseite
• et-2862
• Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

4.6 (481) · € 29.00 · Auf Lager

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis - The Lancet

Sex-specific lesion topographies explain outcomes after acute ischemic stroke

The Neurotoxicity of Tissue Plasminogen Activator? - Jaspreet Kaur, Zonghang Zhao, Gary M. Klein, Eng H. Lo, Alastair M. Buchan, 2004

Sex-specific responses to stroke

Sex differences in IV thrombolysis treatment for acute ischemic stroke

Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase

Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen

Gonadal hormone regulation as therapeutic strategy after acute intracerebral hemorrhage - Michael L James, Thomas Christianson, Daniel Woo, Nicolas Kam King Kon, 2017

Recombinant tissue plasminogen activators (rtPA): A review - Gurman - 2015 - Clinical Pharmacology & Therapeutics - Wiley Online Library

Thrombolysis Treatment for Acute Stroke: Issues of Efficacy and Utilization in Women - Mathew J Reeves, Thomas Wilkins, Lynda D Lisabeth, Lee H Schwamm, 2011